Novel transcript, antisense to ABL1 and EXOSC2 (ENSG00000306514)

This transcript ("novel transcript, antisense to ABL1 and EXOSC2", ENSG00000306514) is annotated as a long non-coding RNA gene in the human genome. The sequence is antisense to both the ABL1 gene, which encodes a protein tyrosine kinase, and the EXOSC2 gene, which encodes a non-catalytic subunit of the RNA exosome complex that is crucial for RNA processing and degradation[1][5][7]. No experimentally validated molecular function, therapeutic relevance, or clinical utility is published. Its classification as "novel transcript" and antisense orientation suggest it may impact the expression of neighboring genes, but the lack of functional, disease, or drug association precludes its use as a canonical therapeutic target. Structured target annotation should default to null or "other" until additional biological characterization is published.